While conventional antidiabetic therapies such as metformin, sulfonylureas, insulin, GLP-1 receptor agonists, and SGLT-2 inhibitors have been reported to be effective in managing diabetes, they are unfortunately associated with several limitations and health-related side effects [10]. The gene discussed is INS; the disease is diabetes mellitus.